RO 7049389

Drug Profile

RO 7049389

Alternative Names: RO7049389

Latest Information Update: 18 May 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Roche
  • Class Antivirals; Small molecules
  • Mechanism of Action Viral core protein modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Hepatitis B

Most Recent Events

  • 27 Jun 2018 Roche plans a phase I trial for Hepatitis B in China , (NCT03570658)
  • 11 Apr 2018 Efficacy, pharmacokinetics, pharmacodynamics and adverse events from a phase I trial in chronic Hepatitis B presented at The International Liver Congress 2018 (LIC-2018)
  • 11 Apr 2018 Pharmacodynamics data from preclinical studies in Hepatitis B presented at The International Liver Congress 2018 (ILC-2018)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top